Posted inAI Oncology Pathology & Lab Medicine
Harnessing Cancer-Testis Antigens for Precision Immunotherapy in Head and Neck Cancer
This study identifies specific cancer-testis antigens (CTAs) as promising targets for personalized immunotherapy in head and neck squamous cell carcinoma (HNSCC), validated across multiomic datasets to enhance therapeutic precision.

